Emergent Health Corp (EMGE)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 6, 2026, 9:30 AM EST
-87.50%
Market Cap 42.70K
Revenue (ttm) 119.57K
Net Income (ttm) -288.76K
Shares Out 426.95M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 488,407
Open 0.0001
Previous Close 0.0001
Day's Range 0.0001 - 0.0001
52-Week Range 0.0000 - 0.0011
Beta -6.98
RSI 47.77
Earnings Date n/a

About Emergent Health

Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. Its products comprise Vita-Stim, a nutrient that enhances the immune system, nourishes stem cells, and maintains health; Neuvitale, which nourishes stem cells and acts as a methyl donor to protect DNA; Hungarest, a diet aid that controls appetite in the brain and stomach; EmergentO2, water oxygenator, which increases oxygen in the blood stream; and products for reducing facial wrinkles. The company distributes its products through health food... [Read more]

Sector Healthcare
Founded 2006
Employees 7
Stock Exchange OTCMKTS
Ticker Symbol EMGE
Full Company Profile

Financial Performance

In 2021, Emergent Health's revenue was $119,567, a decrease of -28.48% compared to the previous year's $167,191. Losses were -$288,764, 264.9% more than in 2020.

Financial Statements

News

There is no news available yet.